A successful technocrat of global standing, Ms. Kiran Mazumdar-Shaw heads India's leading biopharmaceutical enterprise, Biocon. She is highly respected in the corporate world and has been named among TIME magazine’s ‘100 Most Influential People in the World.' She has also featured in Fierce Biotech's list of 'World’s 25 Most Influential People in Biopharma' and is recognized among Forbes '100 Most Powerful Women' globally. U.S.-based Chemical Heritage Foundation recently conferred Ms. Mazumdar-Shaw with the ‘2014 Othmer Gold Medal' and Germany-based Kiel Institute for the World Economy awarded her its coveted '2014 Global Economy Prize' for Business.
Ms. Mazumdar-Shaw is a part of the U.S. Pharmacopeial Convention (USP) Board of Trustees and is also a Member of the USP Biologics Advisory Group. She has served on the Board of Science Foundation, Ireland. Ms. Mazumdar-Shaw is the founder member of Karnataka's Vision Group on Biotechnology and currently chairs this forum. She also serves on the National Advisory Council of the Government's Department of Biotechnology, where she has been instrumental in bringing government, industry and academia together to chart a clear and progressive growth path for Biotechnology in India. Ms. Mazumdar-Shaw serves as Member, Governing Body and General Body of the Indian Pharmacopoeia Commission, an autonomous body of the Government of India. Ms. Mazumdar-Shaw is also on the honorary board of advisors of The National Society of High School Scholars (NSHSS), US.
She is a part of the Prime Minister's Council on Trade & Industry in India and the US-India CEO Forum. She is also a member sof the Governing Council of National Foundation for Corporate Governance, Ministry of Corporate Affairs, Government of India and a member of the Union Commerce Ministry-instituted committee to advise the government on India's export promotion strategy. Additionally, she is a member of the Eminent Persons Group of the Competition Commission of India and a co-opted member on the new Board of Governors of the Indian Council for Research on International Economic Relations (ICRIER).
She is a founder member of the Society for the formation of "Institute for Stem Cell Biology and Regenerative Medicine". Ms. Mazumdar-Shaw has been nominated as Member of the Board of Trade, Directorate General of Foreign Trade, Ministry of Commerce & Industry. Moreover, she serves on the Global Advisory Committee for "Women and the Green Economy Campaign" (WAGE)™ initiative that engages with women in business, government and NGO leaders to help create and develop a global green economy.
Ms. Mazumdar-Shaw is the recipient of other prestigious awards, including Nikkei Asia Prize for Regional Growth and the 'Veuve Clicquot Initiative For Economic Development for Asia' Award.
Ms. Mazumdar-Shaw is also an Independent Member of the Board of Infosys, a global leader in consulting, technology and outsourcing solutions.
Her most cherished awards are the national awards, PADMA SHRI (1989) and PADMA BHUSHAN (2005), presented to her by the President of India for her pioneering efforts in biotechnology.
Ms. Mazumdar-Shaw received a graduate honors degree in Zoology from Bangalore University (1973) and qualified as a Master Brewer from Ballarat University, Australia (1975). She also received an honorary Doctorate of Science in 2004, from her alma mater, Ballarat University, in recognition for her pre-eminent contributions to the field of biotechnology. She has also been awarded honorary doctorates from University of Abertay, Dundee, U.K. (2007), University of Glasgow, U.K. (2008) and Heriot-Watt University, Edinburgh, U.K. (2008). She also received an honorary Doctorate of Science from the National University of Ireland (2012) and was conferred an honorary doctorate by Trinity College, Dublin (2012) for her contribution to economic life.
Under her stewardship, Biocon has evolved from its inception in 1978 as an industrial enzymes company to a fully integrated innovation-led Biopharmaceutical enterprise committed to reduce therapy costs of chronic diseases like autoimmune, diabetes and cancer. As an emerging global biopharmaceutical enterprise, serving customers in over 85 countries through innovative products and research services, it is enabling access to affordable healthcare for patients, partners and healthcare systems across the globe. It has successfully developed and taken a range of novel biologics, biosimilars, differentiated small molecules and affordable recombinant human insulin and analogs from 'Lab to Market'. It has a rich pipeline of biosimilars and novel biologics at various stages of development, including a high potential oral insulin. Some of its key brands are INSUGEN®(rh-insulin), BASALOG® (Glargine), CANMAb™ (Trastuzumab), BIOMAb-EGFR® (Nimotuzumab) and ALZUMAb™ (Itolizumab), a 'first in class' anti-CD6 monoclonal antibody.
Biocon has also built a remarkable Research Services business through Syngene and Clinigene that offers integrated discovery and development solutions for both small and large molecules. Biocon is well placed among the top 20 leading biotechnology companies in the world. It had also been ranked at No. 6 on the ‘Top 20 Biopharma Employers’ list for 2013 by Science magazine.
Ms Mazumdar-Shaw’s commitment to affordable healthcare extends beyond business. She is passionately focused on innovation led healthcare solutions for sustainable and affordable healthcare for the marginalized communities. Her philanthropic initiatives include an innovative micro-health insurance program based on delivering cashless healthcare through primary healthcare clinics in rural areas of Karnataka, an education initiative based on math education for school children in government schools as well as making quality cancer care affordable to a larger patient population. She has established the 1,400-bed Mazumdar-Shaw Cancer Center (MSCC) in Bangalore in partnership with renowned heart surgeon Dr Devi Shetty to deliver affordable world-class cancer care services to patients irrespective of socio-economic status.
More recently she has also established the Mazumdar Shaw Center for Translational Research (MSCTR), a non-profit research institute dedicated to developing scientific breakthroughs resulting in more effective treatments for a wide range of human diseases and conditions. Ms. Mazumdar-Shaw is also focusing on ensuring access to affordable healthcare for the marginalized communities through telemedicine initiatives like eLaaj, preventive screenings for oral and cervical cancer etc.
Her philanthropic efforts have got her featured in the Forbes’ List of ‘Heroes of Philanthropy’.
She is also the Honorary Consul of Ireland in Bangalore.
Ms. Mazumdar-Shaw is married to John Shaw, a Scotsman and Indophile, who headed a leading textiles MNC Madura Coats from 1991-1998 as Chairman and Managing Director. John Shaw is currently the Vice-Chairman, Biocon Limited.